Determining the prognosis of patients with myelodysplastic syndromes using machine learning

Long term data from JULIET trial, using tisagenlecleucel for patients with relapsed or treatment-resistant DLBCL

Initial report of the Beat AML umbrella study for previously untreated AML

Machine learning algorithm improves prognosis accuracy for patients with myelodysplastic syndromes

Cancer care in areas of drug conflict

Cancer control in small island developing states

The best way to collaborate

Developing global curricula for cancer control

Cancer control in areas of conflict

The value for money of drugs and other tech

Universal health coverage and cancer care

The quality of the HARMONY Data Platform